Editorial

Sonja von Aulock

U2

From in vivo to in vitro: The medical device testing paradigm shift

Dayna Kerecman Myers, Alan M. Goldberg, Albrecht Poth, Michael F. Wolf, Joseph Carraway, James McKim, Kelly P. Coleman, Richard Hutchinson, Ronald Brown, Harald F. Krug, Anthony Bahinski, Thomas Hartung

479-500

Non-animal approaches for toxicokinetics in risk evaluations of food chemicals

Ans Punt, Ad A. C. M. Peijnenburg, Ron L. A. P. Hoogenboom, Hans Bouwmeester

501-514

Evaluation of the GARD assay in a blind Cosmetics Europe study

Henrik Johansson, Robin Gradin, Andy Forreryd, Maria Agemark, Kathrin Zeller, Angelica Johansson, Olivia Larne, Erwin van Vliet, Carl Borrebaeck, Malin Lindstedt

515-523

The borderline range of toxicological methods: Quantification and implications for evaluating precision

Maria Leontaridou, Daniel Urbisch, Susanne N. Kolle, Katharina Ott, Denis S. Mulliner, Silke Gabbert, Robert Landsiedel

525-538

The GARD platform for potency assessment of skin sensitizing chemicals

Kathrin S. Zeller, Andy Forreryd, Tim Lindberg, Robin Gradin, Aakash Chawade, Malin Lindstedt

539-559

Adaptation of the KeratinoSens™ skin sensitization test to animal-product-free cell culture

Nathalie Belot, Bushra Sim, Christopher Longmore, Lottie Roscoe, Carol Treasure

560-564

Progress towards the replacement of the rabbit blood sugar bioidentity assay by an in vitro test for batch release of insulins in quality control

Rüdiger Hack, Sabrina Rueggeberg, Lea Schneider, Dirk Mayert, Norbert Tennagels, Stefan Welte, Birgit Niederhaus, Wilfried Arz, Dirk Usener, Götz Troschau, Johannes Meiwes, Jochen Maas

565-566